Cebix

spacer_gradation2.jpg

Recent News

November 18, 2011 Webcast: From the C-peptide symposium in Lisbon, Portugal September 12, 2011 more>>

September 07, 2011 Cebix to Chair Symposium on C-Peptide and the Pathophysiology of Diabetes at European Association for the Study of Diabetes Annual Meeting 2011 more>>

Blog

February 04, 2011 National Diabetes Fact Sheet 2011- CDC more>>

September 28, 2010 Presented by James Callaway, Chief Operating Officer and President of Research and Development Cebix Inc. more>>

Publications

July 06, 2011

C-Peptide reverses TGF-B1-induced changes in renal proximal tubular cells: implications for treatment of diabetic nephropathy more>>
C-Peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats more>>
Effects of C-Peptide on glomerular and renal size and function in diabetic rats more>>
Beneficial effects of C-Peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus more>>
Influence of Combined C-Peptide and Insulin Administration on Renal Function and Metabolic Control in Diabetes Type 1 more>>

February 04, 2011

National Diabetes Fact Sheet 2011- CDC more>>

June 25, 2010

Cellular and physiological effects of C-peptide more>>

June 19, 2010

Amelioration of Sensory Nerve Dysfunction by C-Peptide in Patients With Type 1 Diabetes more>>
C-Peptide Replacement Therapy and Sensory Nerve Function in Type 1 Diabetic Neuropathy more>>
Human C-peptide antagonises high glucose-induced endothelial dysfunction through the nuclear factor-kB pathway more>>

June 18, 2010

Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein more>>